NeoTherapeutics Inc. Gets New President
Dow Jones
NeoTherapeutics Inc., an Irvine pharmaceuticals company, said Monday that Rajesh C. Shrotriya has been named president, effective Sept. 1.
A company spokeswoman said Shrotriya assumes the post from Alvin Glasky, who will remain chief executive, chairman and chief scientific officer.
In a news release Monday, the company said Shrotriya was most recently executive vice president and chief scientific officer of SuperGen Inc.
